SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-23-014864
Filing Date
2023-06-08
Accepted
2023-06-08 16:17:21
Documents
1
Period of Report
2023-06-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7337
  Complete submission text file 0000899243-23-014864.txt   8753
Mailing Address 4819 EMPEROR BOULEVARD SUITE 340 DURHAM NC 27703
Business Address 4819 EMPEROR BOULEVARD SUITE 340 DURHAM NC 27703 415-505-0809
Satsuma Pharmaceuticals, Inc. (Issuer) CIK: 0001692830 (see all company filings)

IRS No.: 813039831 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O FOAMIX PHARMACEUTICALS LTD. 2 HOLZMAN STREET, WEIZMANN SCIENCE PARK REHOVOT L3 76704
Business Address
Harsch Mutya (Reporting) CIK: 0001727809 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39041 | Film No.: 231002138